推薦產品
product name
羰基氰化物 4-（三氟甲氧基）苯腙, ≥98% (TLC), powder
品質等級
化驗
≥98% (TLC)
形狀
powder
顏色
yellow
mp
174-175 °C (dec.) (lit.)
溶解度
95% ethanol: soluble
儲存溫度
2-8°C
SMILES 字串
FC(F)(F)Oc1ccc(N\N=C(/C#N)C#N)cc1
InChI
1S/C10H5F3N4O/c11-10(12,13)18-9-3-1-7(2-4-9)16-17-8(5-14)6-15/h1-4,16H
InChI 密鑰
BMZRVOVNUMQTIN-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
一般說明
FCCP是一种质子载体（H+ 离子载体），也是线粒体氧化磷酸化的解偶联剂。它能够促使质膜和线粒体膜去极化。FCCP可影响细胞钙离子参与的各种活动。它还能抑制K+ 背景电流和诱导小量内向电流，降低0.1单位的pH，以及诱导胞内[Na+]升高。FCCP能刺激Mg2+-ATP酶活性，抑制β-淀粉样蛋白生成，以及模拟选择性谷氨酸激动剂N-甲基-D-天冬氨酸(NMDA)对线粒体超氧化物产生的影响。
應用
碳酰腈4-三氟甲氧基苯腙(FCCP)可作为细胞培养的解偶联剂：用于研究其对产热脂肪细胞的影响，用于研究其对小鼠线粒体β-氧化的作用，用于研究其对小鼠骨髓来源树突状细胞的代谢影响。
訊號詞
Danger
危險分類
Acute Tox. 4 Oral - Aquatic Chronic 4 - Eye Dam. 1 - Skin Corr. 1B - Skin Sens. 1
儲存類別代碼
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
個人防護裝備
Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
分析證明 (COA)
輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號，寫有 ‘Lot’或‘Batch’.。
客戶也查看了
Sheng-Po Chiu et al.
Sensors (Basel, Switzerland), 19(14) (2019-07-25)
Electric cell-substrate impedance sensing (ECIS) is an emerging technique for sensitively monitoring morphological changes of adherent cells in tissue culture. In this study, human mesenchymal stem cells (hMSCs) were exposed to different concentrations of carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) for 20
Aleksandar Rakovic et al.
Cell death and differentiation, 26(8), 1428-1441 (2018-10-31)
The Parkinson's disease (PD)-related ubiquitin ligase Parkin and mitochondrial kinase PINK1 function together in the clearance of damaged mitochondria. Upon mitochondrial depolarization, Parkin translocates to mitochondria in a PINK1-dependent manner to ubiquitinate outer mitochondrial membrane proteins. According to the current
Isa Mambetsariev et al.
Journal of clinical medicine, 8(7) (2019-07-19)
Small cell lung cancer (SCLC) is an aggressive neuroendocrine disease with an overall 5 year survival rate of ~7%. Although patients tend to respond initially to therapy, therapy-resistant disease inevitably emerges. Unfortunately, there are no validated biomarkers for early-stage SCLC
Maria Plataki et al.
JCI insight, 5 (2019-07-10)
The prevalence of obesity is rising worldwide and obese patients comprise a specific population in the intensive care unit. Acute respiratory distress syndrome (ARDS) incidence is increased in obese patients. Exposure of rodents to hyperoxia mimics many of the features
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務